282 related articles for article (PubMed ID: 17202797)
1. [Adrenoleukodystrophy: structure and function of ALDP, and intracellular behavior of mutant ALDP with naturally occurring missense mutations].
Takahashi N; Morita M; Imanaka T
Yakugaku Zasshi; 2007 Jan; 127(1):163-72. PubMed ID: 17202797
[TBL] [Abstract][Full Text] [Related]
2. Adrenoleukodystrophy: subcellular localization and degradation of adrenoleukodystrophy protein (ALDP/ABCD1) with naturally occurring missense mutations.
Takahashi N; Morita M; Maeda T; Harayama Y; Shimozawa N; Suzuki Y; Furuya H; Sato R; Kashiwayama Y; Imanaka T
J Neurochem; 2007 Jun; 101(6):1632-43. PubMed ID: 17542813
[TBL] [Abstract][Full Text] [Related]
3. [Adrenoleukodystrophy: molecular pathogenesis and development of therapeutic agents].
Morita M
Yakugaku Zasshi; 2007 Jul; 127(7):1059-64. PubMed ID: 17603264
[TBL] [Abstract][Full Text] [Related]
4. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
5. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
6. Co-expression of mutated and normal adrenoleukodystrophy protein reduces protein function: implications for gene therapy of X-linked adrenoleukodystrophy.
Unterrainer G; Molzer B; Forss-Petter S; Berger J
Hum Mol Genet; 2000 Nov; 9(18):2609-16. PubMed ID: 11063720
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of the adrenoleukodystrophy protein (ALDP) and disease pathogenesis.
Gärtner J; Dehmel T; Klusmann A; Roerig P
Endocr Res; 2002 Nov; 28(4):741-8. PubMed ID: 12530690
[TBL] [Abstract][Full Text] [Related]
8. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
[TBL] [Abstract][Full Text] [Related]
9. Role of ALDP (ABCD1) and mitochondria in X-linked adrenoleukodystrophy.
McGuinness MC; Lu JF; Zhang HP; Dong GX; Heinzer AK; Watkins PA; Powers J; Smith KD
Mol Cell Biol; 2003 Jan; 23(2):744-53. PubMed ID: 12509471
[TBL] [Abstract][Full Text] [Related]
10. Mutational and protein analysis of patients and heterozygous women with X-linked adrenoleukodystrophy.
Feigenbaum V; Lombard-Platet G; Guidoux S; Sarde CO; Mandel JL; Aubourg P
Am J Hum Genet; 1996 Jun; 58(6):1135-44. PubMed ID: 8651290
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
12. Very-long-chain fatty acid metabolism in adrenoleukodystrophy protein-deficient mice.
Yamada T; Shinnoh N; Kondo A; Uchiyama A; Shimozawa N; Kira J; Kobayashi T
Cell Biochem Biophys; 2000; 32 Spring():239-46. PubMed ID: 11330052
[TBL] [Abstract][Full Text] [Related]
13. Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters.
Liu LX; Janvier K; Berteaux-Lecellier V; Cartier N; Benarous R; Aubourg P
J Biol Chem; 1999 Nov; 274(46):32738-43. PubMed ID: 10551832
[TBL] [Abstract][Full Text] [Related]
14. Biochemical aspects of X-linked adrenoleukodystrophy.
Kemp S; Wanders R
Brain Pathol; 2010 Jul; 20(4):831-7. PubMed ID: 20626744
[TBL] [Abstract][Full Text] [Related]
15. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
16. Topology of ATP-binding domain of adrenoleukodystrophy gene product in peroxisomes.
Contreras M; Sengupta TK; Sheikh F; Aubourg P; Singh I
Arch Biochem Biophys; 1996 Oct; 334(2):369-79. PubMed ID: 8900413
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of ALDP in X-linked adrenoleukodystrophy.
Watkins PA; Gould SJ; Smith MA; Braiterman LT; Wei HM; Kok F; Moser AB; Moser HW; Smith KD
Am J Hum Genet; 1995 Aug; 57(2):292-301. PubMed ID: 7668254
[TBL] [Abstract][Full Text] [Related]
18. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional insights of the human peroxisomal ABC transporter ALDP.
Jia Y; Zhang Y; Wang W; Lei J; Ying Z; Yang G
Elife; 2022 Nov; 11():. PubMed ID: 36374178
[TBL] [Abstract][Full Text] [Related]
20. Human adrenoleukodystrophy protein and related peroxisomal ABC transporters interact with the peroxisomal assembly protein PEX19p.
Gloeckner CJ; Mayerhofer PU; Landgraf P; Muntau AC; Holzinger A; Gerber JK; Kammerer S; Adamski J; Roscher AA
Biochem Biophys Res Commun; 2000 Apr; 271(1):144-50. PubMed ID: 10777694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]